This HTML5 document contains 111 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q100444166
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована 5 жовтня 2020 artículu científicu espublizáu n'ochobre de 2020 scientific article published on 05 October 2020 wetenschappelijk artikel article scientifique publié en 2020
p:P577
wds:Q100444166-DD64EFFC-6608-40E3-92C0-14BE270BD235
wdt:P577
2020-10-05T00:00:00Z
p:P2860
wds:Q100444166-5F8C188F-1AD7-464E-B47F-B7FC1F5A60FE wds:Q100444166-70DAFB4E-6CA7-461D-B3FC-193751462E85 wds:Q100444166-81D5BF85-75CE-4C0A-B21D-1DF4F30025C8 wds:Q100444166-859A59F2-B8D3-4D19-B6F3-C51B5F94AD27 wds:Q100444166-3AF9FF97-A06C-4C69-8CC9-527765CBBECC wds:Q100444166-3BAF8D6B-18A8-4175-8171-14B0FB512CD9 wds:Q100444166-4444C074-4961-42B3-80B3-22CA76BD133A wds:Q100444166-49F9974B-C679-479C-AA22-BA904057F59E wds:Q100444166-4DFF5CC3-A249-4B24-BF01-F9B91DA8E6BE wds:Q100444166-56B625B3-A84D-4AB5-8027-EFB50703D32A wds:Q100444166-AE1E2D29-DE15-4214-8F9A-4C89BC740F32 wds:Q100444166-CE2F0343-A434-4773-867E-33D41B3D0775 wds:Q100444166-D550AE67-BA2C-4AD5-8833-25B4A805D062 wds:Q100444166-E6225D63-00F5-45F5-9F16-CD6230A8AADE wds:Q100444166-8BA7DE6B-7185-451A-AECF-571CF049C367 wds:Q100444166-90F678E0-0F41-4E18-9FE9-E3B81D02206B wds:Q100444166-95754627-0F62-4EA5-8642-A3AE827609E8 wds:Q100444166-9D5DD5C6-9AC1-4D3D-8356-98A11AAD1A7B wds:Q100444166-A40CA91D-9B77-4200-BCF8-F22ED08C3006 wds:Q100444166-A559790F-8DE4-4913-B8C1-17DE428600D1 wds:Q100444166-AB9D5C60-6062-4EC7-B5A1-FD3CC65464DB wds:Q100444166-089E1059-731C-4EDB-BF02-3D5A295BAF1A wds:Q100444166-1075FF0A-ACD4-4E91-94AF-AA8A92AA11D6 wds:Q100444166-19D4F5C4-0143-42EC-9095-D02586E9D00B wds:Q100444166-3221CF40-FCD8-4394-BD3F-F24CF96A7408 wds:Q100444166-04DDE361-7DCA-41E2-BB59-8DD59ACAFBC0 wds:Q100444166-ED1A962D-C10D-4680-B274-3524559BFF4E wds:Q100444166-F6C31E6F-FA69-447A-B7D6-37C24C928D7E wds:Q100444166-F73196AC-5CE7-4FFA-B82A-3EDC172CCBE4 wds:Q100444166-FA02F05D-2405-43D7-834B-B244FAD061E2
wdt:P2860
wd:Q92014362 wd:Q46440284 wd:Q87412594 wd:Q87908479 wd:Q28260798 wd:Q90496575 wd:Q39599579 wd:Q88292103 wd:Q39044195 wd:Q51044872 wd:Q94595785 wd:Q38193206 wd:Q33384087 wd:Q87812699 wd:Q46493539 wd:Q24794580 wd:Q93221320 wd:Q92015588 wd:Q91952550 wd:Q39197752 wd:Q96109911 wd:Q36506814 wd:Q90575837 wd:Q83767469 wd:Q93176303 wd:Q90646484 wd:Q91703665 wd:Q87759574 wd:Q96127105 wd:Q94478176
p:P2093
wds:Q100444166-FE830BF3-393D-4CEB-8631-B8A0C7161DB3 wds:Q100444166-ED491A62-B2B3-4240-AE1A-AF01F7743072 wds:Q100444166-201BA2EE-2649-48A4-8931-EFDF0F8A81F1 wds:Q100444166-2E5F3208-1688-4635-B7F5-804394D74EC4 wds:Q100444166-19F780B7-5663-4BA2-A2FC-99E1F9BD10F7 wds:Q100444166-AC394D52-0883-44E0-BBF9-C3AF1CF70072 wds:Q100444166-77F9A7C7-9738-4BF8-9F6A-A3EFFE486B81 wds:Q100444166-59297AEB-DB65-4011-B332-DC056DCE5AA5
wdt:P2093
R Messmann M Arzt L S Maier C Schmid C Birner M Tafelmeier Z Provaznik S Lebek
rdfs:label
ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease
skos:prefLabel
ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease
schema:name
ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease
p:P50
wds:Q100444166-DB36EA3D-D823-4A5C-BC28-80E56BF7A15B
wdt:P50
wd:Q90140816
p:P1476
wds:Q100444166-354CD422-BF93-458F-8C57-5015DD142951
wdt:P1476
ACE inhibitor/angiotensin II receptor blocker treatment and hemodynamic factors are associated with increased cardiac mRNA expression of ACE2 in patients with cardiovascular disease
p:P31
wds:Q100444166-A8F726A2-8BBD-4F8A-B907-DBE06FEBF0AB
wdt:P31
wd:Q13442814
p:P921
wds:Q100444166-3EED7548-98C2-430B-B1F9-CABE0B99C023
wdt:P921
wd:Q389735
p:P698
wds:Q100444166-37DA6B1C-0959-451E-A46C-E4E20433775D
wdtn:P698
n9:33017071
wdt:P698
33017071
p:P1433
wds:Q100444166-57A4EB3C-8164-4C4B-B0DD-DC6E15E48897
wdt:P1433
wd:Q5017954
p:P356
wds:Q100444166-DC74D5DD-1BAB-4648-AB65-C1DB62007981
wdtn:P356
n11:EJHF.2020
wdt:P356
10.1002/EJHF.2020
p:P932
wds:Q100444166-7B7E78BA-BA80-4A61-A68A-10833E980A18
wdt:P932
7675329